Profile
Substance use treatment; Transitional housing, halfway house, or sober home; Residential/24-hour residential; Long-term residential; General Hospital (including VA hospital); Buprenorphine used in Treatment; Naltrexone used in Treatment; No formal relationship with prescribing entity; Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere; In-network prescribing entity; No formal relationship with prescribing entity; Accepts clients using MAT but prescribed elsewhere; Acamprosate (Campral®); Disulfiram; Buprenorphine with naloxone; Buprenorphine without naloxone; Buprenorphine (extended-release, injectable); Naltrexone (oral); Naltrexone (extended-release, injectable); Lofexidine; Clonidine; Medication for mental disorders; Nicotine replacement; Non-nicotine smoking/tobacco cessation; Substance use disorder counseling; 12-step facilitation; Private non-profit organization; State Substance use treatment agency; The Joint Commission; Federal, or any government funding for substance use treatment programs; Medicare; Medicaid; Private health insurance; Cash or self-payment; State-financed health insurance plan other than Medicaid; Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ); Comprehensive substance use assessment; Screening for tobacco use; Breathalyzer or blood alcohol testing; Drug or alcohol urine screening; Discharge Planning; Naloxone and overdose education; Self-help groups; Housing services; Assistance with obtaining social services; HIV or AIDS education, counseling, or support; Hepatitis education, counseling, or support; Health education services other than HIV/AIDS or hepatitis; Substance use disorder education; Smoking/vaping/tobacco cessation counseling; Individual counseling; Group counseling; Smoking permitted in designated area; Adults; Young adults; Female; Male; Case management service; Social skills development